About Representatives Opportunities
About GenStat Group (Prof. Markus Scholz) at the Institute for Medical Informatics, Statistics and Epidemiology (IMISE), Leipzig University. We develop and apply advanced statistics and AI/ML to molecular, clinical and population data—covering study design and causal inference, longitudinal/survival modelling, multi-omics integration, single-cell & spatial analytics, and predictive/mechanistic models for systems medicine and pandemic preparedness. We lead methods WPs, build FAIR/reproducible pipelines, and co-create clinically actionable decision support with healthcare partners.
Representatives Peter Ahnert
Senior Scientist
Leipzig University - Medical Faculty - IMISE
Marketplace (4) Expertise
Offering expertise of the Group of Prof. Markus Scholz
Integration of multi-omics & clinical data for insights into molecular mechanisms
Diagnostic tools (biomarkers, genetic tests, companion diagnostics) Personalised treatment pathways (tailored therapies, precision dosing) Screening & early detection programs (risk stratification, predictive tools) Data integration & interoperability solutions (EHRs, registries, data platforms) Author Peter Ahnert
Senior Scientist at Leipzig University - Medical Faculty - IMISE
Leipzig, Germany
Expertise
Offering expertise of the group of Prof. Markus Scholz
Advanced statistical methods for analyzing high-dimensional molecular data, time series data, and sparse data sets
Clinical decision support systems for personalised medicine Diagnostic tools (biomarkers, genetic tests, companion diagnostics) Personalised treatment pathways (tailored therapies, precision dosing) Partial adoption of a PM solution (testing selected modules/components) Screening & early detection programs (risk stratification, predictive tools) Author Peter Ahnert
Senior Scientist at Leipzig University - Medical Faculty - IMISE
Leipzig, Germany
Expertise
Offering Expertise of the group of Prof. Markus Scholz
Developing predictive models for disease progression, treatment response, and personalized medicine using AI, statistics, and external data
Clinical decision support systems for personalised medicine Theranostics (combined diagnostic + therapeutic approaches) Diagnostic tools (biomarkers, genetic tests, companion diagnostics) Personalised treatment pathways (tailored therapies, precision dosing) Screening & early detection programs (risk stratification, predictive tools) Author Peter Ahnert
Senior Scientist at Leipzig University - Medical Faculty - IMISE
Leipzig, Germany
Expertise
Offering expertise of the group of Prof. Markus Scholz
Advancing single-cell sequencing with bioinformatics to uncover cellular heterogeneity, gene regulation, and insights into complex diseases.
Clinical decision support systems for personalised medicine Theranostics (combined diagnostic + therapeutic approaches) Diagnostic tools (biomarkers, genetic tests, companion diagnostics) Personalised treatment pathways (tailored therapies, precision dosing) Screening & early detection programs (risk stratification, predictive tools) Author Peter Ahnert
Senior Scientist at Leipzig University - Medical Faculty - IMISE
Leipzig, Germany